N@N

SMITH & NEPHEW PLC -SPON ADR (NYSE:SNN), Down By 5.28% ($3.03) From $57.400 After BUYINS.NET Report Predicted Stock Would Go Do

^{Published on 2011-05-04 09:25:24 - WOPRAI}
 

May 4, 2011 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a provider of unique trading technologies, released a report on Tuesday, April 12th 2011 stating that SMITH & NEPHEW PLC -SPON ADR (NYSE:SNN) was expected to go Down due to the Bearish conditions presented in the following report. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?sym=snn&id=159836

At the time this story was written, SMITH & NEPHEW PLC -SPON ADR (NYSE:SNN) is Down By $3.03 (5.28%) since the BUYINS.NET report was released.

The movement of stock prices in the days and weeks leading to and following specific fundamental or technical events may follow a predictable pattern. Many companies stock price histories show random or unpredictable movements around certain events. But some seem to repeat the same pattern quarter after quarter, year after year. We use powerful computers to uncover those events and correlations to generate predictions with high probabilities of generating very specific returns within very specific time periods.

The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php

SMITH & NEPHEW PLC -SPON ADR (NYSE:SNN) - Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices in the orthopaedics, endoscopy, and advanced wound management sectors. The company operates through three segments: Orthopaedics, Endoscopy, and Advanced Wound Management. The Orthopaedics segment offers reconstruction implants, including hip, knee, and shoulder joints, as well as ancillary products, such as bone cement and mixing systems for use in the cemented reconstruction joint surgery. This segment also provides trauma fixation products consisting of internal and external devices and orthobiological materials for use in the stabilisation of fractures and deformity correction procedures; and clinical therapies products comprising bone growth stimulation, and joint fluid therapies. The Endoscopy segment develops and commercializes endoscopic techniques, educational programs, and value-added services for surgeons to treat and repair soft tissue and articulating joints. It offers specialized devices and fixation systems to repair damaged tissue; fluid management and insufflation equipment for surgical access; digital cameras, digital image capture, scopes, light sources, and monitors to assist with visualization; and radiofrequency wands, electromechanical and mechanical blades, and hand instruments for resecting damaged tissue. The Advanced Wound Management segment provides initial wound bed preparation and full wound closure products. This segments products are targeted at chronic wounds connected with the older population, including pressure sores and venous leg ulcers; and products for the treatment of wounds, such as burns and invasive surgery. Smith & Nephew plc serves medical and surgical service providers worldwide. The company was founded in 1856 and is headquartered in London, the United Kingdom.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor market-maker surveillance system tracking Level II market-makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 30 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies specifically for this report, but may have been compensated up to $1,200 per month in the past for unrelated data or report services. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net